Adelaide Research & Scholarship: Search

Search

Search:
for

Current filters:

Start a new search

Add filters:

Results/Page | Sort items by In order Authors/record

Results 11-20 of 39 (Search time: 0.002 seconds).

previous
1
2
3
4
next

Item hits:

Preview	Issue Date	Title	Author(s)
	2019	Exploring the relationship between ischemic core volume and clinical outcomes after thrombectomy or thrombolysis	Chen, C.; Parsons, M.W.; Levi, C.R.; Spratt, N.J.; Miteff, F.; Lin, L.; Cheng, X.; Lou, M.; Kleinig, T.; Butcher, K.; Dong, Q.; Bivard, A.
	2014	Merkel cell carcinoma of the eyelid management and prognosis	Herbert, H.; Sun, M.; Selva, D.; Fernando, B.; Saleh, G.; Beaconsfield, M.; Collin, R.; Uddin, J.; Meligonis, G.; Leatherbarrow, B.; Ataullah, S.; Irion, L.; McLean, C.; Huilgol, S.; Davis, G.; Sullivan, T.
	2019	Alpha-Blockers as colorectal cancer chemopreventive: findings from a case-control study, human cell cultures, and in vivo preclinical testing	Suzuki, N.; Niikura, R.; Ihara, S.; Hikiba, Y.; Kinoshita, H.; Higashishima, N.; Hayakawa, Y.; Yamada, A.; Hirata, Y.; Nakata, R.; Okamoto, M.; Sano, M.; Kushiyama, A.; Ichinose, M.; Woods, S.L.; Worthley, D.; Iwamoto, Y.; Koike, K.
	2011	Promoter methylation of Wnt antagonists DKK1 and SFRP1 is associated with opposing tumor subtypes in two large populations of colorectal cancer patients	Rawson, J.; Manno, M.; Mrkonjic, M.; Daftary, D.; Dicks, E.; Buchanan, D.; Younghusband, H.; Parfrey, P.; Young, J.; Pollett, A.; Green, R.; Gallinger, S.; McLaughlin, J.; Knight, J.; Bapat, B.
	2015	Phase 2 study of intralesional PV-10 in refractory metastatic melanoma	Thompson, J.; Agarwala, S.; Smithers, B.; Ross, M.; Scoggins, C.; Coventry, B.; Neuhaus, S.; Minor, D.; Singer, J.; Wachter, E.
	2012	Cancer risks for the relatives of colorectal cancer cases with a methylated MLH1 promoter region: data from the colorectal cancer family registry	Levine, A.; Win, A.; Buchanan, D.; Jenkins, M.; Baron, J.; Young, J.; Long, T.; Weisenberger, D.; Laird, P.; McCall, R.; Duggan, D.; Haile, R.
	2014	IGFBP7 is associated with poor prognosis in oesophageal adenocarcinoma and is regulated by promoter DNA methylation	Smith, E.; Ruszkiewicz, A.; Jamieson, G.; Drew, P.
	2014	Added value of soluble tumor necrosis factor-alpha receptor 1 as a biomarker of ESRD risk in patients with type 1 diabetes	Forsblom, C.; Moran, J.; Harjutsalo, V.; Loughman, T.; Waden, J.; Tolonen, N.; Thorn, L.; Saraheimo, M.; Gordin, D.; Groop, P.; Thomas, M.
	2013	Performance of the Glasgow-Blatchford score in predicting clinical outcomes and intervention in hospitalized patients with upper GI bleeding	Bryant, R.; Kuo, P.; Williamson, K.; Yam, C.; Schoeman, M.; Holloway, R.; Nguyen, Q.
	2013	Early molecular response and female sex strongly predict stable undetectable BCR-ABL1, the criteria for imatinib discontinuation in patients with CML	Branford, S.; Yeung, D.; Ross, D.; Prime, J.; Field, C.; Altamura, H.; Yeoman, A.; Georgievski, J.; Jamison, B.; Phillis, S.; Sullivan, B.; Briggs, N.; Hertzberg, M.; Seymour, J.; Reynolds, J.; Hughes, T.